Sucampo Pharmaceuticals, Inc. 4
4 · Sucampo Pharmaceuticals, Inc. · Filed Nov 26, 2013
Insider Transaction Report
Form 4
Miele Stanley G
SVP Sales & Marketing
Transactions
- Exercise of In-Money
Class A Common Stock
2013-11-22$7.50/sh−50,000$375,000→ 173,400 total - Exercise of In-Money
Employee Stock Option (Right to Buy)
2013-11-22$7.50/sh−50,000$375,000→ 173,400 totalExercise: $4.41From: 2013-06-04Exp: 2021-05-02→ Class A Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The date exercisable for a portion of the stock options is 06/04/2013.